Novo Nordisk has launched its blockbuster Wegovy weight-loss drug in China, adding the world’s second-largest economy to its ...

In an interview with The U.S. Sun, Social Security Advisors CEO Matthew Allen said it’s possible for retirees to get the ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention, and more than half a million Americans have a stroke every year. But up ...

"Since more than half of U.S. adults who have taken GLP-1 receptor agonists state the therapy was difficult to afford, ...

STATEN ISLAND, N.Y. -- More Americans may now be able to receive federal assistance in feeding their families thanks to ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Each year, over half a million Americans have a stroke, but up to 80% may be preventable with better nutrition, exercise and ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

Researchers examined the relationship between a diet that provokes inflammation and the risk for irritable bowel syndrome.

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...